Cloudera has integrated the Iceberg REST Catalog across what it describes as a full-lifecycle data and AI platform. The aim is to enable secure, zero-copy data sharing and unified governance across ...
1d
MongoDB Brings Vector and Search Capabilities to Self-Managed Database Offerings for AI Development
MongoDB Inc. (NASDAQ:MDB) provides general purpose database platform worldwide. The company’s core offerings include MongoDB ...
This summary is reviewed by TRD Staff. Compass expanded its presence to Florida's Treasure Coast by adding the 15-agent New Wave Group in Stuart, led by Sara Crombie. The New Wave Group specializes in ...
FILE - New York Liberty forward Breanna Stewart holds the ball during a WNBA basketball game against the Seattle Storm, June 22, 2025, in Seattle. (AP Photo/Lindsey ...
Imagine a clock that doesn't have electricity, but its hands and gears spin on their own for all eternity. In a new study, physicists at the University of Colorado Boulder have used liquid crystals, ...
The new maps, which aim to flip five Democratic seats to favor Republicans, will go into effect for the 2026 midterms, barring court intervention. Sign up for The Brief, The Texas Tribune’s daily ...
New York City mayoral candidate Zohran Mamdani speaks during a press conference in New York City, September 3, 2025. REUTERS NYPD boss Jessica Tisch and her rank and file keep scoring impressive wins ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up for Dispatches, a newsletter that spotlights wrongdoing around the country, to receive our stories in your inbox every ...
WASHINGTON – The Republican-controlled House of Representatives voted on party lines on Aug. 3 to create a special panel to reinvestigate the events of the Jan. 6, 2021 insurrection. In 2022, after 18 ...
As of last month, my wife has restricted our sex life with a new set of rules. She wants us to have sex only on Friday and Saturday nights, claiming that having sex on nights when she has to get up ...
Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback